Nano-X Imaging Ltd. (NNOX) stock soared 16% intraday on Monday, following a bullish analyst report that initiated coverage on the medical imaging technology company with a Buy rating.
D. Boral Capital analyst Jason Kolbert initiated coverage on Nano-X Imaging with a Buy rating and a $23 price target. Kolbert cited the company's innovative Nanox.ARC digital X-ray technology as a disruptive force in the medical imaging market, positioning Nano-X at the forefront of making early cancer detection more accessible and affordable.
The analyst's optimism about Nano-X Imaging's prospects and potential for growth in the rapidly evolving medical imaging space fueled investor enthusiasm, driving the stock's significant intraday surge.